Last Updated: September 29, 2026

Litigation Details for In Re Motion to Compel Production of Documents Pursuant to Subpoena Duces Tecum (D. Mass. 2020)


✉ Email this page to a colleague

« Back to Dashboard


In Re Motion to Compel Production of Documents Pursuant to Subpoena Duces Tecum (D. Mass. 2020)

Docket 1:20-mc-91045 Date Filed 2020-01-22
Court District Court, D. Massachusetts Date Terminated 2020-02-07
Cause No cause code entered Assigned To Allison Dale Burroughs
Jury Demand Referred To
Patents 8,198,262; 8,673,939; 8,735,428; 8,828,427; 9,993,467
Link to Docket External link to docket
Small Molecule Drugs cited in In Re Motion to Compel Production of Documents Pursuant to Subpoena Duces Tecum
The small molecule drug covered by the patents cited in this case is ⤷  Start Trial .

Details for In Re Motion to Compel Production of Documents Pursuant to Subpoena Duces Tecum (D. Mass. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-01-22 External link to document
2020-01-21 2 inter alia, U.S. Patent Nos. 8,198,262; 8,673,939; and 8,735,428 (collectively the “patents-in-suit”), all…company formerly-known as EntreMed discovered, patented, and began clinical development on the use of …release regarding issuance of thalidomide analog patents to EntreMed)); Ex. 3 (DEFS_POM_00003852 (press…was the individual who initially discovered—and patented—that thalidomide and its analogues, including…91045 Document 2 Filed 01/22/20 Page 6 of 11 patents covering 3-amino-thalidomide (i.e., pomalidomide External link to document
2020-01-21 3 true and correct copy of United States Patent No. 8,198,262, Ex. A to ECF No. 1, Complaint in Celgene…10 is a true and correct copy of United States Patent No. 8,673,939, Ex. B to ECF No. 1, Complaint in…11 is a true and correct copy of United States Patent No. 8,735,428, Ex. C to ECF No. 1, Complaint in External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.